Indaptus Therapeutics Inc. – Market and Recent Corporate Developments
Trading Performance
- Closing price (09:10 PM Central Europe, 22 Oct 2026): USD 3.00
- Intraday movement: +6.76 % over the last 24 hours.
- Trading volume (last 24 hours): USD 1.7 million.
- Shares outstanding: 133.2 million.
- Market capitalization: USD 394.4 million.
- Simple moving average (200 days): USD 2.28.
- 52‑week high: USD 5.96 (4 Jun 2026).
- 52‑week low: USD 0.92 (18 Aug 2026).
- Month‑end change: –20.8 % compared with the previous month’s close.
Recent Corporate Actions
| Date | Event | Details |
|---|---|---|
| 16 Oct 2026 | Private placement | Issued approximately 20 million shares of common stock. Proceeds raised from the sale. |
| 16 Oct 2026 | 8‑K filing | Disclosed completion of the private placement and related terms. |
| 21 Oct 2026 | Schedule 13D amendment | Updated beneficial ownership after sale of ~1.3 million shares by a key investor; adjusted shareholder percentage following the private placement. |
No additional material events have been reported.
Related Stock Activity (Last 24 hours)
| Company | Ticker | Price (USD) | Change (%) | Market Capitalization (USD mn) |
|---|---|---|---|---|
| Crane Harbor Acquisition | CRAN | 10.09 | 0.00 | 473.2 |
| Hamilton Beach Brand | HBB | 33.11 | –3.59 | 464.8 |
| Apex Treasury | APXT | 10.14 | 0.00 | 465.6 |
| Diamedica Therapeutics | DMAC | 8.59 | +0.23 | 468.6 |
| Vireo Growth | VREOF | 8.51 | –1.92 | 470.8 |
Company Overview
Indaptus Therapeutics Inc. is a clinical‑stage biopharmaceutical company headquartered in New York, United States. The company focuses on developing proprietary platforms that use bacteria to activate innate and adaptive immune pathways. Indaptus Therapeutics is listed on the Nasdaq stock exchange and provides information on its operations at www.indaptusrx.com .
